Article PDF
Avoid common mistakes on your manuscript.
References
Wallace DC (1999) Mitochondrial diseases in man and mouse.Science 283: 1482–1487
Saraste M (1999) Oxidative phosphorylation at thefin de siècle.Science 283: 1488–1492
Holt IJ, Harding AE, Morgan-Hughes JA (1988) Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies.Nature 331, 717–719
Wallace DC, Singh G, Lott MT et al. (1988) Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy.Science 242, 1427–1430
Chinnery PF and Turnbull DM (1999) Mitochondrial DNA and Disease.Lancet 354 (suppl I): 17–21
Leonard JV, Shapira AVH (2000) Mitochondrial respiratory chain disorders II: neurodegenerative disorders and nuclear gene defects.Lancet 355: 389–394
Smeitink JAM, Loeffen JLCM, Triepels RH, Smeets RJP, Trijbels JMF, van den Heuvel LP (1998) Nuclear genes of human complex I of the mitochondrial electron transport chain: state of the art.Hum Mol Genet 7 (10): 1573–1579
DiMauro S (1999) Mitochondrial Encephalomyopathies: Back to Mendelian Genetics.Ann Neurol 45: 693–694
Cavanagh JB, Harding BN (1994). Pathogenic factors underlying the lesions in Leigh’s disease: tissue responses to cellular energy deprivation and their clinico-pathological consequences.Brain 117: 1357–1376
Di Donato S (2000) Disorders related to mitochondrial membranes.J Inher Metab Dis, in press
Bourgeron T, Rustin P, Chretien D, Birch-Machin M, Bourgeois M, Viegas-Péquignot E, Munnich A, Rötig A (1995) Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency.Nature Genetics 11: 144–149
De Coo IFM, Renier WO, Ruitenbeek W, Ter Laak HJ, Bakker M, Schägger H, Van Oost BA, Smeets HJM (1999) A 4-Base Pair Deletion in the Mitochondrial Cytochromeb Gene Associated with Parkinsonism/MELAS Overlap Syndrome.Ann Neurol 45 (1): 130–133
Andreu AL, Hanna MG, Reichmann H, Bruno C, Penn AS, Tanji K, Pallotti F, Ivata S, Bonilla E, Lach B, Morgan-Hughes J, Di Mauro S (1999) Exercise intolerance due to mutations in the cytochromeb gene of mitochondrial DNA.New Engl J Med 341: 1037–44
DiMauro S, Servidei S, Zeviani M, DiRocco M, De Vivo DC, Di Donato S, Uziel G, Berry K, Hoganson G, Johnsen SD, Johnson PC (1987) Cytochromec Oxidase Deficiency in Leigh Syndrome.Ann Neurol 22: 498–506
Adams PL, Lightowlers RN, Turnbull DM (1997) Molecular Analysis of Cytochromec Oxidase Deficiency in Leigh’s Syndrome.Ann Neurol 41: 268–270
Comi GP, Bordoni A, Salani S, Franceschina L, Sciacco M, Prelle A, Fortunato F, Zeviani M, Napoli L, Bresolin N, Moggio M, Ausenda CD, Taanman JW, Scarlato G (1998). Cytochrome c oxidase subunit I microdeletion in a patient with motor neuron disease.Ann Neurol 43: 110–16
Holt IJ, Harding AE, Perry PKH, Morgan-Hughes JA (1990) A new mitochondrial disease associated with mitochondrial DNA heteroplasmy.Am J Hum Genet 46: 428–33
Tatuch Y, Christodoulou J, Feigenbaum A, Clarke JTR, Wherret J, Smith C, Rudd N, Petrova-Benedict R, Robinson BH (1992) Heteroplasmic mtDNA mutation (T→G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high.Am J Hum Genet 50: 852–855
Poyton RO, McEwen JE (1996) Crosstalk between nuclear and mitochondrial genomes.Ann Rev Biochem 65: 563–607
Poyton RO (1998) Assembling a time bomb-cytochromec oxidase and disease.Nature Genetics 20: 316–317
Munaro M, Tiranti V, Sandonà D, Lamantea E, Uziel G, Bisson R, Zeviani M (1997) A single cell complementation class is common to several cases of cytochromec oxidase-defective Leigh’s syndrome.Hum Mol Gen 6 (2): 221–228
Tiranti V, Hoertnagel K, Carrozzo R, Galimberti C, Munaro M, Granatiero M, Zelante L, Gasparini P, Marzella R, Rocchi M, Bayona-Bafaluy MP, Enriquez JA, Uziel G, Bertini E, Dionisi-Vici C, Franco B, Meitinger T, Zeviani M (1998) Mutations of SURF-1 in Leigh disease associated with cytochromec oxidase deficiency.Am J Hum Genet 63: 1609–1621
Zhu Z, Yao J, Johns T, Fu K, De Bie I, Macmillan C, Cuthbert AP, Newbold RF, Wang J, Chevrette M, Brown GK, Brown RM, Shoubridge EA (1998) SURF1, encoding a factor involved in the biogenesis of cytochromec oxidase, is mutated in Leigh syndrome.Nature Genetics 20: 337–343
Papadopoulou LC, Sue CM, Davidson MM, Tanji K, Nishino I, Sadlock JE, Krishna S, Walker W, Selby J, Glerum DM, Van Coster R, Lyon G, Scalais G, Lebel R, Kaplan P, Shanske S, De Vivo DC, Bonilla E, Hirano M, Di Mauro SD, Schon EA (1999) Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene.Nature Genet 23, 333–337
Petruzzella V, Tiranti V, Fernandez F, Ianna P, Carrozzo R, Zeviani M (1998) Identification and characterization of human cDNAs specific to BC1, PET 112, SCO1, COX15, and COX 11, five genes involved in the formation and function of the mitochondrial respiratory chain.Genomics 54: 494–504
Campuzano V, Montermini L, Moltò MD, Pianese L, Cossée M, Cavalcanti F, Monros E, Rodius F, Duclos F, Monticelli A, Zara F, Cañizares J, Koutnikova H, Bidichandani SI, Gellera C, Brice A, Truillas P, De Michele G, Filla A, De Frutos R, Palau F, Patel PI, Di Donato S, Mandel JL, Cocozza S, Koenig M, Pandolfo M (1996) Friedreich’s Ataxia: Autosomal Recessive Disease Caused by an intronic GAA Triplet repeat Expansion.Science: 1423–1427
Babcock M, de Silva D, Oaks R, Davis-Kaplan S, Jiralerspong S, Montermini L, Pandolfo M, Kaplan J (1997) Regulation of Mitochondrial Iron Accumulation by Yfh1p, a Putative Homolog of Frataxin.Science 271: 1709–1712
Rötig A, de Lonlay P, Chretien D, Foury F, Koenig M, Sidi D, Munnich A, Rustin P (1997) Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia.Nature Genetics 17: 215–217
Wong A, Yang J, Cavadini P, Gellera C, Lonnerdal B, Taroni F, Cortopassi G (1999) The Friedreich’s ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis.Hum Mol Gen 8 (3): 425–430
Dürr A, Brice Aserdaru M, Rancurel G, Derouesné G, Lyon-Caen O, Agid Y, Fontaine B (1994) The phenotype of “pure” autosomal dominant spastic paraplegia.Neurology 44: 1274–77
Casari G, De Fusco M, Clarmatori S, Zeviani M, Mora M, Fernandez P, De Michele G, Filla A, Cocozza S, Marconi R, Dürr A, Fontaine B, Ballabio A (1998) Spastic Paraplegia and OXPHOS Impairment Caused by Mutations in Paraplegin, a Nuclear-Encoded Mitochondrial Metalloprotease.Cell 93: 973–983
References
Barber R, Gholkar A, Ballard C, Scheltens P, McKeith I, O’Brien JT (1999). Temporal lobe atrophy on MRI in dementia with Lewy bodies: a comparison with Alzheimer’s disease, Vascular dementia and normal ageing.Neurology 52: 1153–1158.
Barber R, Gholkar A, Ballard C, Scheltens P, McKeith I, Perry R, Ince P, Barer D, O’Brien JT (1999). White matter lesions on MRI in dementia with Lewy bodies, Alzheimer’s disease, Vascular dementia and normal ageing.Journal of Neurology, Neurosurgery and Psychiatry 67: 66–93.
Barber R, Gholkar A, Scheltens P, Ballard C, McKeith I, Morris C, O’Brien JT (1999) Apolipoprotein E4, temporal lobe atrophy and white matter lesions in late life dementias.Archives of Neurology 56: 961–965.
Harvey GT, O’Brien JT, Hughes J, McKeith I, Briel R, Ballard C, Gholkar A, Perry R, Ince P (1999). Magnetic Resonance Imaging Differences between Dementia with Lewy Bodies and Alzheimer’s Disease.Psychological Medicine 29: 181–187.
References
Bastian HC. On the symptomatology of total transverse lesions of the spinal cord, with special reference to the condition of the various reflexes. Med-Chir Trans. (Lond) 1890; 73: 151–217.
Diamantopoulos E. Excitability of motor neurones in spinal shock in man. J Neurol Neurosurg Psychiatry 1967; 30: 427–31.
Ashby P, Verrier M, Lightfoot E. Segmental reflex pathways in spinal shock and spinal spasticity in man. J Neurol Neurosurg Psychiatry 1974; 37: 1352–60.
Schadt JC, Barnes CD. Motoneuron membrane changes associated with spinal shock and the Schiff-Sherrington phenomenon. Brain Res 1980; 201: 373–83.
Hiersemenzel LP, Curt A, Dietz V. From spinal shock to spasticity: Neuronal adaptions to a spinal cord injury. Neurology 2000 (in press)
Faist M, Mazevet D, Dietz V, Pierrot-Deseilligny E. A quantitative assessment of presynaptic inhibition of Ia afferents in spastics. Differences in hemiplegics and paraplegics. Brain 1994; 117: 1449–55.
Deschuytere J. H reflexes in muscles of the lower and upper limbs in man: identification and clinical significance. Adv Neurol 1983; 39: 951–60.
O’Dwyer NJ, Ada L. Reflex hyperexcitability and muscle contracture in relation to spastic hypertonia. Curr Opin Neurol 1996; 9: 451–5.
References
Asbury AK, Arnason BG, Adams RD. The inflammatory lesion in idiopathic polyneuritis: its role in pathogenesis. Medicine (Baltimore) 1969, 48:173–215.
Berciano J, García A, Figols et al. Perineurium mediates axonal damage in acute inflammatory demyelinating polyneuropathy. J Neurol 1999, 246, Suppl 1: 27–28.
Bouchard C, Lacroix C, Planté V, Adams D, Chedru F, Guglielmi J-M, Said G. Clinicopathological findings and prognosis of chronic inflammatory demyelinating polyneuropathy, Neurology 1999, 52:498–503.
Dyck PJ, Karnes JL, Lambert EH. Longitudinal study of neuropathic deficits and nerve conduction abnormalities in hereditary motor and sensory neuropathy type 1. Neurology 1989, 39:1302–1308.
England, J. D., Rhee E. K., Said, G., Summer A. J.: Schwann cell degeneration induced by doxorubicin (Adriamycin). Brain 1988, 111:901–914.
Griffin JW, Li CY, Ho TW, et al. Pathology of the motor-sensory axonal Guillain-Barré syndrome. Ann. Neurol. 1996; 39:17–28.
Hartung H-P, vande Méché FGA, Pollard JD. Guillain Barré syndroem, CID Pand other chronic immune-mediated neuropathies. Editorial review. Current Opinion in Neurology, 1998, 11:497–513.
Madrid RE, Wisniewski HM. Axonal degeneration in demyelinating disorders. J Neurocytol 1977, 6:103–117.
Revez T. Axonal lesions in multiple sclerosis: an old story revisited. Editorial. Brain 2000, 123:219–220.
Said G, Saida K, Saida T, Asbury AK. Axonal lesions in acute experimental demyelination: a sequential teased nerve fiber study. Neurology 1981, 31: 413–421.
Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338:278–285.
Reference List
Baker M, Bostock H. (1992) Ectopic activity in demyelinated spinal root axons of the rat. J Physiol Lond 451:539–52.
Bostock H. (1993) Impulse propagation in experimental neuropathy. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF. Peripheral Neuropathy, Third ed. Philadelphia: W. B. Saunders, 109–20.
Bostock H, Sears TA. (1978) The internodal axon membrane: electrical excitability and continuous conduction in segmental demyelination. J Physiol Lond 280:273–301.
Davis FA, Jacobson S. (1971) Altered thermal sensitivity in injured and demyelinated nerve. A possible model of temperature effects in multiple sclerosis. J Neurol Neurosurg Psychiat 34:551–61.
Felts PA, Baker TA, Smith KJ. (1997) Conduction in segmentally demyelinated mammalian central axons. J Neurosci 17:7267–77.
Felts PA, Smith KJ. (1992) Conduction properties of central nerve fibers remyelinated by Schwann cells. Brain Res 574:178–92.
Halliday AM, McDonald WI, Mushin J. (1972) Delayed visual evoked response in optic neuritis. Lancet 1:982–5.
Honmou O, Felts PA, Waxman SG, Kocsis JD. (1996) Restoration of normal conduction properties in demyelinated spinal cord axons in the adult rat by transplantation of exogenous Schwann cells. J Neurosci 16:3199–208.
Kapoor R, Smith KJ, Felts PA, Davies M. (1993) Internodal potassium currents can generate ectopic impulses in mammalian myelinated axons. Brain Res 611:165–9.
Kapoor R, Davies M, Smith KJ (1999) Temporary axonal conduction block and axonal loss in inflammatory neurological disease: a potential role for nitric oxide. Ann NY Acad Sci. 893: 304–308
McDonald WI, Sears TA. (1970) The effects of experimental demyelination on conduction in the central nervous system. Brain 93:583–98.
Moreau T, Coles A, Wing M, Isaacs J, Hale G, Waldmann H et al. (1996) Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis. Brain 119:225–37.
Rasminsky M. (1973) The effects of temperature on conduction in demyelinated single nerve fibers. Arch Neurol 28:287–92.
Rasminsky M. (1980) Ephaptic transmission between single nerve fibres in the spinal nerve roots of dystrophic mice. J Physiol Lond 305:151–69.
Rasminsky M, Sears TA. (1972) Internodal conduction in undissected demyelinated nerve fibres. J Physiol Lond 227:323–50.
Redford EJ, Kapoor R, Smith KJ. (1997) Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. Brain 120:2149–57.
Shrager P, Custer AW, Kazarinova K, Rasband MN, Mattson D. (1998) Nerve conduction block by nitric oxide that is mediated by the axonal environment. J Neurophysiol 79:529–36.
Smith KJ, Blakemore WF, McDonald WI. (1981) The restoration of conduction by central remyelination. Brain 104:383–404.
Smith KJ, Bostock H, Hall SM. (1982) Salatory conduction precedes remyelination in axons demyelinated with lysophosphatidyl choline. J Neurol Sci 54:13–31.
Smith KJ, Felts PA, Kapoor R. (1997) Axonal hyperexcitability: mechanisms and role in symptom production in demyelinating diseases. The Neuroscientist 3:237–46.
Smith KJ, McDonald WI. (1982) Spontaneous and evoked electrical discharges from a central demyelinating lesion. J Neurol Sci 55:39–47.
Waxman SG, Ritchie JM. (1993) Molecular dissection of the myelinated axon. Ann Neurol 33:121–36.
Youl BD, Turano G, Miller DH, Towell AD, Macmanus DG, Moore SG et al. The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. Brain 1991; 114:2437–50.
Rights and permissions
About this article
Cite this article
Berciano, J., Bogousslavsky, J., Brandt, T. et al. Tenth Meeting of the European Neurological Society 18–22 June, 2000, Jerusalem, Israël. J Neurol 247 (Suppl 3), 1–217 (2000). https://doi.org/10.1007/BF03160449
Issue Date:
DOI: https://doi.org/10.1007/BF03160449